MAREX GROUP PLC (MRX) Stock Fundamental Analysis
USA - NASDAQ:MRX - GB00BMT7GT62 - Common Stock
33.81 USD
+0.3 (+0.9%)
33.81 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to MRX. MRX was compared to 237 industry peers in the Capital Markets industry. MRX has a bad profitability rating. Also its financial health evaluation is rather negative. MRX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!
1. Profitability
1.1 Basic Checks
MRX had positive earnings in the past year.
MRX had a positive operating cash flow in the past year.
1.2 Ratios
The Return On Assets of MRX (1.12%) is worse than 63.71% of its industry peers.
MRX has a Return On Equity of 31.32%. This is amongst the best in the industry. MRX outperforms 96.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 31.32% | ||
| ROIC | N/A |
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MRX has a Profit Margin (10.07%) which is comparable to the rest of the industry.
MRX's Profit Margin has improved in the last couple of years.
MRX's Gross Margin of 39.98% is on the low side compared to the rest of the industry. MRX is outperformed by 63.71% of its industry peers.
MRX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 10.07% | ||
| GM | 39.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.18%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, MRX has more shares outstanding
MRX has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.22, we must say that MRX is in the distress zone and has some risk of bankruptcy.
MRX has a Altman-Z score of 0.22. This is in the lower half of the industry: MRX underperforms 70.46% of its industry peers.
MRX has a debt to FCF ratio of 9.64. This is a negative value and a sign of low solvency as MRX would need 9.64 years to pay back of all of its debts.
With a Debt to FCF ratio value of 9.64, MRX perfoms like the industry average, outperforming 55.70% of the companies in the same industry.
A Debt/Equity ratio of 11.17 is on the high side and indicates that MRX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 11.17, MRX is doing worse than 89.87% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 11.17 | ||
| Debt/FCF | 9.64 | ||
| Altman-Z | 0.22 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
MRX has a Current Ratio of 1.09. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, MRX is in line with its industry, outperforming 45.15% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that MRX should not have too much problems paying its short term obligations.
MRX has a Quick ratio of 1.08. This is comparable to the rest of the industry: MRX outperforms 49.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
MRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.86%, which is quite impressive.
The Earnings Per Share has been growing by 50.51% on average over the past years. This is a very strong growth
Looking at the last year, MRX shows a very strong growth in Revenue. The Revenue has grown by 22.42%.
Measured over the past years, MRX shows a very strong growth in Revenue. The Revenue has been growing by 36.98% on average per year.
EPS 1Y (TTM)48.86%
EPS 3Y50.51%
EPS 5YN/A
EPS Q2Q%13.33%
Revenue 1Y (TTM)22.42%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%18.48%
3.2 Future
The Earnings Per Share is expected to grow by 16.42% on average over the next years. This is quite good.
The Revenue is expected to grow by 12.92% on average over the next years. This is quite good.
EPS Next Y26.99%
EPS Next 2Y18.36%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year22.31%
Revenue Next 2Y15.6%
Revenue Next 3Y12.92%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
MRX is valuated reasonably with a Price/Earnings ratio of 9.80.
Based on the Price/Earnings ratio, MRX is valued a bit cheaper than 75.95% of the companies in the same industry.
MRX is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.03 indicates a reasonable valuation of MRX.
Based on the Price/Forward Earnings ratio, MRX is valued cheaply inside the industry as 87.34% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, MRX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.8 | ||
| Fwd PE | 8.03 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRX indicates a rather cheap valuation: MRX is cheaper than 94.94% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.52 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
MRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRX's earnings are expected to grow with 16.42% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y18.36%
EPS Next 3Y16.42%
5. Dividend
5.1 Amount
MRX has a Yearly Dividend Yield of 1.71%.
Compared to an average industry Dividend Yield of 7.96, MRX is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.38, MRX is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.71% |
5.2 History
MRX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DPN/A
EPS Next 2Y18.36%
EPS Next 3Y16.42%
33.81
+0.3 (+0.9%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners50.51%
Inst Owner Change0%
Ins Owners6.62%
Ins Owner ChangeN/A
Market Cap2.46B
Analysts81.54
Price Target51.91 (53.53%)
Short Float %4.43%
Short Ratio2.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.71% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.83%
Min EPS beat(2)-0.13%
Max EPS beat(2)9.79%
EPS beat(4)3
Avg EPS beat(4)9.72%
Min EPS beat(4)-0.13%
Max EPS beat(4)18.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.45%
Min Revenue beat(2)0.89%
Max Revenue beat(2)6.01%
Revenue beat(4)4
Avg Revenue beat(4)4.48%
Min Revenue beat(4)0.89%
Max Revenue beat(4)8.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.72%
PT rev (3m)-1.9%
EPS NQ rev (1m)2.84%
EPS NQ rev (3m)5.63%
EPS NY rev (1m)7.09%
EPS NY rev (3m)10.52%
Revenue NQ rev (1m)4.32%
Revenue NQ rev (3m)6.46%
Revenue NY rev (1m)3.94%
Revenue NY rev (3m)5.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.8 | ||
| Fwd PE | 8.03 | ||
| P/S | 0.71 | ||
| P/FCF | 1.52 | ||
| P/OCF | 1.5 | ||
| P/B | 2.22 | ||
| P/tB | 2.97 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.45
EY10.2%
EPS(NY)4.21
Fwd EY12.46%
FCF(TTM)22.18
FCFY65.61%
OCF(TTM)22.48
OCFY66.5%
SpS47.39
BVpS15.24
TBVpS11.37
PEG (NY)0.36
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 31.32% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 10.07% | ||
| GM | 39.98% | ||
| FCFM | 46.81% |
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.18%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
F-Score5
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 11.17 | ||
| Debt/FCF | 9.64 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 93.16% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 464.71% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 0.22 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)64.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.86%
Cap/Sales(5y)N/A
Profit Quality(3y)452.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.86%
EPS 3Y50.51%
EPS 5YN/A
EPS Q2Q%13.33%
EPS Next Y26.99%
EPS Next 2Y18.36%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)22.42%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%18.48%
Revenue Next Year22.31%
Revenue Next 2Y15.6%
Revenue Next 3Y12.92%
Revenue Next 5YN/A
EBIT growth 1Y-15.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.82%
EBIT Next 3Y13.77%
EBIT Next 5YN/A
FCF growth 1Y58.23%
FCF growth 3Y35.14%
FCF growth 5YN/A
OCF growth 1Y58.37%
OCF growth 3Y35.22%
OCF growth 5YN/A